Study Description: You are invited to participate in a research study aimed at understanding eye health and preventive care behaviors in individuals diagnosed with Multiple Myeloma (MM), Monoclonal Gammopathy of Uncertain Significance (MGUS), or Smoldering Multiple Myeloma (SMM). The purpose of this study is to gather information about eye health, medications, and quality of life among patients with these conditions. The study involves completing a cross-sectional survey that will take approximately 3-5 minutes of your time.

 

Study Procedures: If you agree to participate, you will be asked to complete a survey with 12 questions about your medical history, medications, and eye health. You will also have the option to connect your electronic medical records to the survey, allowing researchers to review your drug history and eye surgical interventions.

 

Inclusion Criteria: To participate, you must be at least 18 years old and have a self-reported diagnosis of MGUS, SMM, or MM.

 

Risks and Benefits:  There are no anticipated risks. While there are no direct benefits for participating, the information collected will contribute to improving eye health care for patients with MM and precursor conditions in the future.

 

Participation: Your participation in this study is entirely voluntary. You have the right to withdraw at any time without consequence.

 

Contact Information: If you have any questions or concerns about the study, you can contact HealthTree Patient Navigators (support@healthtree.org).

 

Consent: By participating in this study, you indicate that you have read this consent form, understood its contents, and voluntarily agree to participate.